Literature DB >> 1750767

Diamorphine infusion in the preterm neonate.

A C Elias-Jones1, D A Barrett, N Rutter, P N Shaw, S S Davis.   

Abstract

The effects of diamorphine were studied in 34 premature neonates who were given a loading dose of 50 micrograms/kg of diamorphine followed by a constant rate intravenous infusion of 15 micrograms/kg/hour. Small but significant falls were noted in blood pressure (at 30 minutes) and heart rate (at 30 minutes, six hours, and 12 hours) after administration of diamorphine, but these did not appear to cause any clinical deterioration and were thought to be related to the sedative effect of the drug. A significant fall in respiration rate at 30 and 60 minutes reflected the desired intention to encourage synchronisation of the infants' breathing with the ventilator. The mean (SD) plasma concentration of morphine measured during the infusion at steady state was 62.5 (22.8) ng/ml (range 20 to 98 ng/ml). The data suggest that this dosage regimen of diamorphine is safe. It results in plasma concentrations of morphine in the premature neonate which are comparable with those that are known to provide effective analgesia in the child and adult.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750767      PMCID: PMC1590275          DOI: 10.1136/adc.66.10_spec_no.1155

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  The metabolism of morphine and heroin in man.

Authors:  U Boerner
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

2.  Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life.

Authors:  R Bhat; G Chari; A Gulati; O Aldana; R Velamati; H Bhargava
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

3.  The diposi tion of morphine in surgical patients.

Authors:  B A Berkowitz; S H Ngai; J C Yang; J Hempstead; S Spector
Journal:  Clin Pharmacol Ther       Date:  1975-06       Impact factor: 6.875

4.  Effect of pancuronium and pethidine on heart rate and blood pressure in ventilated infants.

Authors:  V M Miall-Allen; A G Whitelaw
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

5.  Hazards of analgesia for newborn infants.

Authors:  N Marlow; A M Weindling; R W Cooke
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 6.  Pain and its effects in the human neonate and fetus.

Authors:  K J Anand; P R Hickey
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

7.  Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety.

Authors:  G Koren; W Butt; H Chinyanga; S Soldin; Y K Tan; K Pape
Journal:  J Pediatr       Date:  1985-12       Impact factor: 4.406

8.  The pharmacokinetics of heroin in patients with chronic pain.

Authors:  C E Inturrisi; M B Max; K M Foley; M Schultz; S U Shin; R W Houde
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

9.  Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

Authors:  B Dahlström; A Tamsen; L Paalzow; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

10.  Morphine kinetics in children.

Authors:  B Dahlström; P Bolme; H Feychting; G Noack; L Paalzow
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

View more
  7 in total

1.  Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation.

Authors:  M I Levene; M W Quinn
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

2.  Cardiovascular effects of an intravenous bolus of morphine in the ventilated preterm infant.

Authors:  N Rutter; N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

3.  The pharmacokinetics and physiological effects of buprenorphine infusion in premature neonates.

Authors:  D A Barrett; J Simpson; N Rutter; T Kurihara-Bergstrom; P N Shaw; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

4.  An in vitro study of diamorphine permeation through premature human neonatal skin.

Authors:  D A Barrett; N Rutter; S S Davis
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

5.  Randomised double blind trial of morphine versus diamorphine for sedation of preterm neonates.

Authors:  C M Wood; J A Rushforth; R Hartley; H Dean; J Wild; M I Levene
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

6.  Randomised, double blind trial of two loading dose regimens of diamorphine in ventilated newborn infants.

Authors:  D P Barker; J Simpson; M Pawula; D A Barrett; P N Shaw; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

7.  Pharmacokinetics of morphine infusion in premature neonates.

Authors:  R Hartley; M Green; M Quinn; M I Levene
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.